Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 1, 2007, Pages 19-25

  Von Knethen, Andreas ^a   Soller, Mathias ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Inflammation; Sepsis; T cells

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CIGLITAZONE; CURCUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BINDING SITE; CELL DEATH; GENE EXPRESSION; GENE REPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER INJURY; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PREMEDICATION; PROMOTER REGION; PROTEIN SECRETION; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; PPAR GAMMA; SEPSIS;

EID: 33847130951     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0005-y     Document Type: Review

References (49)

1. Abdelrahman M., Collin M. and Thiemermann C. (2004): The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock, 22, 555-561.
2. Annane D., Bellissant E. and Cavaillon J. M. (2005): Septic shock. Lancet, 365, 63-78.
3. Appel S., Mirakaj V., Bringmann A., Weck M. M., Grunebach F. and Brossart P. (2005): PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood, 106, 3888-3894.
4. Beutler B. and Rietschel E. T. (2003): Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol., 3, 169-176.
5. Bodles A. M., Varma V. Yao-Borengasser A., Phanavanh B., Peterson C. A., McGehee R. E. Jr., Rasouli N., Wabitsch M. and Kern P. A. (2006): Pioglitazone induces apoptosis of macrophages in human adipose tissue. J. Lipid Res., 47, 2080-2088.
6. Bone R.C., Fisher C. J. Jr., Clemmer T. P., Slotman G. J., Metz C. A. and Balk R. A. (1989): Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit. Care Med., 17, 389-393.
7. Brun-Buisson C. (2000): The epidemiology of the systemic inflammatory response. Intensive Care Med., 26 (suppl. 1), S64-S74.
8. Buras J. A., Holzmann B. and Sitkovsky M. (2005): Animal models of sepsis: setting the stage. Nat. Rev. Drug Disc., 4, 854-865.
9. Chen F., Wang M., O'Connor J. P., He M., Tripathi T. and Harrison L. E. (2003): Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J. Cell. Biochem., 90, 732-744.
10. Chen Y. C., Shen S. C. and Tsai S. H. (2005): Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim. Biophys. Acta, 1743, 291-304.
11. Collin M. and Thiemermann C. (2003): The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. Eur. J. Pharmacol., 476, 257-258.
12. Collin M., Abdelrahman M. and Thiemermann C. (2004): Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock. Eur. J. Pharmacol., 486, 233-235.
13. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M. D., Colombel J. F. and Auwerx J. (2001): Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med., 193, 827-838.
14. Desvergne B., Michalik L. and Wahli W. (2006): Transcriptional regulation of metabolism. Physiol. Rev., 86, 465-514.
15. Dhillon S. S., Mahadevan K., Bandi V., Zheng Z., Smith C. W. and Rumbaut R. E. (2005): Neutrophils, nitric oxide, and microvascular permeability in severe sepsis. Chest, 128, 1706-1712.
16. Docke W. D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H. D. and Kox W. (1997): Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med., 3, 678-681.
17. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H. and Ikeda H. (2003): Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther., 100, 171-194.
18. Gupta R. A., Polk D. B., Krishna U., Israel D. A., Yan F., DuBois R. N. and Peek R. M. Jr. (2001): Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J. Biol. Chem., 276, 31059-31066.
19. Hotchkiss R. S., Swanson P. E., Cobb J. P., Jacobson A., Buchmann J. G. and Karl I. E. (1997): Apoptois in lymphoid and parenchymal cells during sepsis: findings in normal T- and B-cell deficient mice. Crit. Care Med., 25, 1298-1307.
20. Hotchkiss R. S. and Karl I. E. (2003): The pathophysiology and treatment of sepsis. N. Engl. J. Med., 348, 138-150.
21. Hotchkiss R. S., Coopersmith C. M. and Karl I. E. (2005): Prevention of lymphocyte apoptosis - a potential treatment. Clin. Infect. Dis., 41 (suppl. 7), S465-S469.
22. Hunter P. (2006): Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock. EMBO Rep., 7, 667-669.
23. Johann A. M., von Knethen A., Lindemann D. and Brune B. (2006): Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ., 13, 1533-1540.
24. Joshi V. D., Kalvakolanu D. V. and Cross A. S. (2003): Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis. FEBS Lett., 555, 180-184.
25. Kaplan J. M., Cook J. A., Hake P. W., O'Connor M., Burroughs T. J. and Zingarelli B. (2005): 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock, 24, 59-65.
26. Kodera Y., Takeyama K., Murayama A., Suzawa M., Masuhiro Y. and Kato S. (2000): Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators. J. Biol. Chem., 275, 33201-33204.
27. Li M., Pascual G. and Glass C. K. (2000): Peroxisome proliferator- activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol., 20, 4699-4707.
28. Martin G. S., Mannino D. M., Eaton S. and Moss M. (2003): The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 348, 1546-1554.
29. Oberholzer C., Oberholzer A., Clare-Salzler M. Moldawer L. L. (2001): Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J., 15, 879-892.
30. Osuchowski M. F., Welch K., Siddiqui J. and Remick D. G. (2006): Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality. J. Immunol., 177, 1967-1974.
31. Padilla J., Kaur K., Cao H. J., Smith T. J. and Phipps R. P. (2000): Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. J. Immunol., 165, 6941-948.
32. Padilla J., Leung E. and Phipps R. P. (2002): Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin. Immunol., 103, 22-33.
33. Pascual G., Fong A. L., Ogawa S., Gamliel A., Li A. C., Perissi V., Rose D. W., Willson T. M., Rosenfeld M. G. and Glass C. K. (2005): A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 437, 759-763.
34. Ricote M., Li A. C., Willson T. M., Kelly C. J. and Glass C. K. (1998): The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 391, 79-82.
35. Riedemann N. C., Guo R. F. and Ward P. A. (2003): The enigma of sepsis. J. Clin. Invest., 112, 460-467.
36. Riedemann N. C., Guo R. F. and Ward P. A. (2003): Novel strategies for the treatment of sepsis. Nat. Med., 9, 517-524.
37. Shipley J. M. and Waxman D. J. (2003): Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Mol. Pharmacol., 64, 355-364.
38. Siddiqui A. M., Cui X., Wu R., Dong W., Zhou M., Hu M., Simms H. H. and Wang P. (2006): The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator- activated receptor-gamma. Crit. Care Med., 34, 1874-1882.
39. Singh S. and Evans T. W. (2006): Organ dysfunction during sepsis. Intensive Care Med., 32, 349-360.
40. Soller M., Tautenhahn A., Brune B., Zacharowski K., John S., Link H. and von Knethen A. (2006): Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J. Leukoc. Biol., 79, 235-243.
41. Subbaramaiah K., Lin D. T., Hart J. C. and Dannenberg A. J. (2001): Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J. Biol. Chem., 276, 12440-12448.
42. Tautenhahn A., Brune B. and von Knethen A. (2003): Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis. J. Leukoc. Biol., 73, 665-672.
43. Tinsley K. W., Chen S. L., Buchman T. G., Hui J. J., Karl I. E. and Hotchkiss R. S. (2000): Caspases-2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock, 13, 1-7.
44. von Knethen A. and Brune B. (2001): Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J., 15, 535-544.
45. Wang P., Anderson P. O., Chen S., Paulsson K. M., Sjogren H. O. and Li S. (2001): Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. Int. Immunopharmacol., 1, 803-812.
46. Wesche-Soldato D. E., Lomas-Neira J. L., Perl M., Jones L., Chung C. S. and Ayala A. (2005): The role and regulation of apoptosis in sepsis. J. Endotoxin Res., 11, 375-382.
47. Yamakawa-Karakida N., Sugita K., Inukai T., Goi K., Nakamura M., Uno K., Sato H., Kagami K., Barker N. and Nakazawa S. (2002): Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Cell Death Differ., 9, 513-526.
48. Yang X. Y., Wang L. H., Chen T., Hodge D. R., Resau J. H., DaSilva L. and Farrar W. L. (2000): Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J. Biol. Chem., 275, 4541-4544.
49. Yki-Jarvinen H. (2004): Thiazolidinediones. N. Engl. J. Med., 351, 1106-1118.